Annals of Oncology

News:

Enrico Roggero

More on cancer vaccine
Ann Oncol 10: 1-2.
[PDF] [Request Permissions]

Large increase in support for US cooperative groups
Ann Oncol 10: 2.
[PDF] [Request Permissions]

Sunshine over ESMO in Athens
Ann Oncol 10: 2-3.
[PDF] [Request Permissions]

Huge increase in NIH budget
Ann Oncol 10: 3-4.
[PDF] [Request Permissions]

Not too much new from the German government
Ann Oncol 10: 4.
[PDF] [Request Permissions]

WHO proposes international treaty against tobacco
Ann Oncol 10: 4-5.
[PDF] [Request Permissions]

Oncologist confirmed as FDA Commissioner
Ann Oncol 10: 5.
[PDF] [Request Permissions]

Awards, appointments
Ann Oncol 10: 5.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 10: 5-7.
[PDF] [Request Permissions]

Book reviews:

F. Nolé

Book review
Ann Oncol 10: 8.
[PDF] [Request Permissions]

Editorials:

F. Cavalli

The first decade
Ann Oncol 10: 9.
[PDF] [Request Permissions]

M. E. E. Sabbioni

Are physicians aware of what patients know about what physicians know?
Ann Oncol 10: 11-12.
[PDF] [Request Permissions]

Special articles:

M. A. Shipp, M. D. Abeloff, K. H. Antman, G. Carroll, A. Hagenbeek, M. Loeffler, E. Montserrat, J. A. Radford, G. Salles, N. Schmitz, M. Symann, J. O. Armitage, B. Coiffier, and T. Philip

International Consensus Conference on high-dose therapy with hematopoietic stem-cell transplantation in aggressive non-Hodgkin's lymphomas: Report of the jury
Ann Oncol 10: 13-19.
[PDF] [Request Permissions]

Review:

S. A. Luykx-de Bakker, T. D. de Gmijl, R. J. Scheper, J. Wagstaff, and H. M. Pinedo

Dendritic cells: A novel therapeutic modality
Ann Oncol 10: 21-27.
[PDF] [Request Permissions]

Review on evidence-based cancer medicine:

S. E. Straus and D. L. Sackett

Applying evidence to the individual patient
Ann Oncol 10: 29-32.
[PDF] [Request Permissions]

Rapid publication:

W. Kreis, D. R. Budman, J. Fetten, A. L. Gonzales, B. Barile, and V. Vinciguerra

Phase I trial of the combination of daily estramustine phosphate and intermittent docetaxel in patients with metastatic hormone refractory prostate carcinoma
Ann Oncol 10: 33-38.
[Abstract] [PDF] [Request Permissions]

Original articles:

M. Gattellari, P. N. Butow, M. H. N. Tattersall, S. M. Dunn, and C. A. MacLeod

Misunderstanding in cancer patients: Why shoot the messenger?
Ann Oncol 10: 39-46.
[Abstract] [PDF] [Request Permissions]

L. Mauriac, G. MacGrogan, A. Avril, M. Durand, A. Floquet, M. Debled, J. M. Dilhuydy, and F. Bonichon Institut Bergonié Bordeaux Groupe Sein (IBBGS)

Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: A unicentre randomized trial with a 124-month median follow-up
Ann Oncol 10: 47-52.
[Abstract] [PDF] [Request Permissions]

R. L. Basser, R. Abraham, L. Bik To, R. M. Fox, and M. D. Green

Cardiac effects of high-dose epirubicin and cyclophosphamide in women with poor prognosis breast cancer
Ann Oncol 10: 53-58.
[Abstract] [PDF] [Request Permissions]

M. Lazzarino, E. Orlandi, M. Montillo, A. Tedeschi, G. Pagnucco, C. Astori, A. Corso, E. Brusamolino, L. Simoncini, E. Morra, and C. Bernasconi

Fludarabine, cyclophosphamide, and dexamethasone (FluCyD) combination is effective in pretreated low-grade non-Hodgkin's lymphoma
Ann Oncol 10: 59-64.
[Abstract] [PDF] [Request Permissions]

D. Hao, L. M. DiFrancesco, P. M. A. Brasher, C. deMetz, D. S. Fulton, L. M. DeAngelis, and P. A. J. Forsyth

Is primary CNS lymphoma really becoming more common? A population-based study of incidence, clinicopathological features and outcomes in Alberta from 1975 to 1996
Ann Oncol 10: 65-70.
[Abstract] [PDF] [Request Permissions]

J. H. Loge, A. Foss Abrahamsen, Ø Ekeberg, and S. Kaasa

Reduced health-related quality of life among Hodgkin's disease survivors: A comparative study with general population norms
Ann Oncol 10: 71-77.
[Abstract] [PDF] [Request Permissions]

T. Krause, N. Eisenmann, M. Reinhardt, J. Bathmann, C. Altehoefer, J. Finke, and E. Moser

Bone marrow scintigraphy using Technetium-99m antigranulocyte antibody in malignant lymphomas
Ann Oncol 10: 79-85.
[Abstract] [PDF] [Request Permissions]

G. Freyer, A. Dazord, M. Schlumberger, B. Conte-Devolx, B. Ligneau, V. Trillet-Lenoir, and G. M. Lenoir

Psychosocial impact of genetic testing in familial medullary-thyroid carcinoma: A multicentric pilot-evaluation
Ann Oncol 10: 87-95.
[Abstract] [PDF] [Request Permissions]

M. J. P. Welters, B. J. M. Braakhuis, A. J. Jacobs-Bergmans, A. Kegel, R. A. Baan, W. J. F. van der Vijgh, and A. M. J. Fichtinger-Schepman

The potential of platinum-DNA adduct determination in ex vivo treated tumor fragments for the prediction of sensitivity to cisplatin chemotherapy
Ann Oncol 10: 97-103.
[Abstract] [PDF] [Request Permissions]

Clinical case:

S. Cascinu, F. Graziano, and G. Catalan

Chemotherapy for advanced pancreatic cancer: It may no longer be ignored
Ann Oncol 10: 105-109.
[Abstract] [PDF] [Request Permissions]

Short reports:

K. Mimori, H. Ueo, C. Shirasaka, T. Shiraishi, M. Yamagata, M. Haraguchi, and M. Mori

Up-regulated pyrimidine nucleoside phosphorylase in breast carcinoma correlates with lymph node metastasis
Ann Oncol 10: 111-113.
[Abstract] [PDF] [Request Permissions]

M. J. Rummel, K. U. Chow, E. Jäger, D. K. Hossfeld, L. Bergmann, H.-D. Peter, M.-L. Hansmann, A. Meyer, D. Hoelzer, and P. S. Mitrou

Treatment of mantle-cell lymphomas with intermittent two-hour infusion of cladribine as first-line therapy or in first relapse
Ann Oncol 10: 115-117.
[Abstract] [PDF] [Request Permissions]

P. Schöffski, G. Catimel, A. S. T. Planting, J.-P. Droz, J. Verweij, D. Schrijvers, L. Gras, A. Schrijvers, J. Wanders, A. R. Hanauske, and European Organization for Research and Treatment of Cancer (EORTC) and Early Clinical Studies Group (ECSG)

Docetaxel and cisplatin: An active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck: Results of a phase II study of the EORTC Early Clinical Studies Group
Ann Oncol 10: 119-122.
[Abstract] [PDF] [Request Permissions]

Letters to the editor:

S. Yalçin

Treatment of soft-tissue sarcomas: High-dose ifosfamide or combination of ifosfamide and etoposide?
Ann Oncol 10: 123.
[PDF] [Request Permissions]

J.M. Buesa and Spanish Group for Research on Sarcomas (GEIS)

This letter was referred to the author, who responds as follows:
Ann Oncol 10: 123-124.
[PDF] [Request Permissions]

L. Pagano, L. Teofili, L. Mele, M. Piantelli, F.O. Ranelletti, F. Equitani, L.M. Larocca, and G. Leone

Oral ipriflavone (7-isopropoxyisoflavone) treatment for elderly patients with resistant acute leukemias
Ann Oncol 10: 124-125.
[PDF] [Request Permissions]

I.H. G{diaeresis}ll{diaeresis} and S. Marangoz

Telomerase or telomersyn?
Ann Oncol 10: 125-126.
[PDF] [Request Permissions]

Instructions to Authors:

Instruction to authors
Ann Oncol 10: 127-128.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.